RHUMBLINE ADVISERS - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 47 filers reported holding NEON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$57,000
+119.2%
21,7200.0%0.00%
Q4 2019$26,000
-29.7%
21,7200.0%0.00%
Q3 2019$37,000
-60.6%
21,720
+9.3%
0.00%
Q2 2019$94,000
+20.5%
19,870
+64.8%
0.00%
Q1 2019$78,00012,0580.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$25,718,0007.00%
HARVARD MANAGEMENT CO INC 505,871$1,335,0000.21%
ARMISTICE CAPITAL, LLC 1,050,000$2,772,0000.17%
Maven Securities LTD 381,150$1,006,0000.12%
Athanor Capital, LP 547,651$1,446,0000.09%
MONETA GROUP INVESTMENT ADVISORS LLC 102,652$271,0000.03%
TERRIL BROTHERS, INC. 19,300$51,0000.02%
MEEDER ASSET MANAGEMENT INC 5,878$15,0000.00%
ACADIAN ASSET MANAGEMENT LLC 94,908$251,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEON THERAPEUTICS INC shareholders